INS and Obesity: It has been found that EGCG administration can improve the interference of nutritional obesity on insulin signal, reduce the accumulation of lipids in liver tissue, and interfere with the TLR4-mediated inflammatory response pathway and the key molecule of insulin signal pathway in liver tissue, thus balancing the redox state, relieving inflammation [31–33].